This is a preprint.
Association between Accelerometer-Measured Irregular Sleep Duration and Longitudinal Changes in Body Mass Index in Older Adults
- PMID: 39574880
- PMCID: PMC11581088
- DOI: 10.1101/2024.10.30.24316315
Association between Accelerometer-Measured Irregular Sleep Duration and Longitudinal Changes in Body Mass Index in Older Adults
Update in
-
Association between accelerometer-measured irregular sleep duration and longitudinal changes in body mass index in older adults.Int J Obes (Lond). 2025 Jul;49(7):1280-1289. doi: 10.1038/s41366-025-01768-8. Epub 2025 Apr 6. Int J Obes (Lond). 2025. PMID: 40189712 Free PMC article.
Abstract
Irregular sleep duration may disrupt circadian rhythms and contribute to metabolic, behavioral, and mood changes, potentially increasing the risk for obesity. However, quantitative data on the relationship between sleep duration irregularity and weight change are lacking. In this prospective study, we analyzed data from 10,572 participants (mean age: 63 years) in the UK Biobank who wore accelerometers for a week between 2013-2015 and had two body mass index (BMI; kg/m2) measurements on average 2.5 years apart. Irregular sleep duration was assessed by the within-person standard deviation (SD) of 7-night accelerometer-measured sleep duration. Participants with sleep duration SD >60 minutes versus ≤30 minutes had 0.24 kg/m2 (95% CI: 0.08, 0.40) higher BMI change (kg/m2), standardized to three-year intervals, and 80% (95% CI: 1.28, 2.52) higher risk for incident obesity, after adjusting for sociodemographic factors, shift work, and baseline BMI or follow-up period (p-trend<0.02 for both). These associations remained consistent after adjusting for lifestyle, comorbidities, and other sleep factors, including sleep duration. Age, sex, baseline BMI, and genetic predisposition to higher BMI (measured with a polygenic risk score) did not appear to modify the association. Since irregular sleep duration is common, trials of interventions targeting sleep irregularity might lead to new public health strategies that tackle obesity.
Conflict of interest statement
Conflicts of Interest: MKR reports receiving consultancy fees from Eli Lilly and has modest stock ownership in GSK, unrelated to this work. The other authors have no conflicts of interest to declare.
References
-
- World Health Organization. Obesity and overweight; Key facts 2021. [Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
-
- World Obesity Federation. World obesity atlas 2022. London; 2022.
-
- Blüher M. Obesity: global epidemiology and pathogenesis. Nature Reviews Endocrinology. 2019;15(5):288–98. - PubMed
-
- Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Journal of the American college of cardiology. 2014;63(25 Part B):2985–3023. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources